New Study Of CONCERTA Showed Significant Improvement Of ADHD Symptom Management In Adults Compared To Placebo

Boston, MA - Adults with Attention Deficit Hyperactivity Disorder (ADHD) treated with CONCERTA OROS methylphenidate HCl Extended-release Tablets showed significant improvements in ADHD symptom management compared to adults taking placebo, according to study results presented recently at a major psychiatric medical meeting.

"Pharmacological treatment of children and adolescents with ADHD is clearly established but relatively less is known about the treatment of adults with ADHD," notes the study's medical director, Sally Berry, M.D., Ph.D., of Johnson & Johnson Pharmaceutical Research & Development, L.L.C. "We're encouraged that the CONCERTA findings presented today – in which CONCERTA significantly improved ADHD symptom management in adults – can benefit the growing body of knowledge in this important therapeutic area. "The data presented recently are part of a Supplemental New Drug Application (sNDA) submitted in August 2007 to the Food and Drug Administration for use of CONCERTA to treat adults with ADHD. CONCERTA is already approved for the treatment of ADHD in children and adolescents ages six to 17.

SOURCE: ADHD